Dover Corporation · DOV · FY2025 Q1 · Calendar Q2 2025
Dover: Strong margins and bookings, but tariffs pressure guidance
The supplied analysis supports a mixed but constructive view: resilient bookings, margin expansion, and secular demand in clean energy, biopharma, and thermal connectors support the growth case, while tariff exposure and lowered guidance are meaningful counterevidence.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about DOV FY2025 Q1
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior-quarter analysis, Dover moved from maintained guidance to modestly lowered full-year revenue and EPS guidance as tariff uncertainty became more prominent. The company still reported continued bookings growth and record margin performance, while emphasizing pricing actions, cost productivity, capacity expansion, and focused acquisitions.
Guidance delta
Management modestly lowered full-year revenue and EPS guidance because of tariff uncertainty.
Key takeaways
- Adjusted EPS increased 19% year over year and adjusted EBITDA margin reached a record 24% in the quarter.
- Organic bookings grew for a sixth consecutive quarter, with book-to-bill above 1 across all segments.
- Clean energy, biopharma components, and data-center thermal connectors remained the main growth drivers.
- Tariff exposure, especially in Chinese steel and vehicle services, led to pricing mitigation and lower full-year guidance.
Management priorities
- Expand capacity and consolidate rooftops in the second half of 2025
- Invest in automation and productivity to reduce fixed costs
- Scale clean-energy, biopharma, and thermal-connector platforms
- Pursue acquisitions in high-growth end markets
Follow DOV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 24, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 24, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jun 4, 2026 |
| Seaport Global | Buy | Buy | Maintain | Apr 28, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 24, 2026 |
| Baird | Outperform | Outperform | Maintain | Apr 24, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 13, 2026 |
| Wells Fargo | Overweight | Equal Weight | Upgrade | Mar 17, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jan 30, 2026 |
| UBS | Buy | Neutral | Upgrade | Jan 5, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jun 13, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Dec 12, 2024 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Oct 28, 2024 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | Apr 12, 2023 |
| B of A Securities | Buy | Buy | Maintain | Apr 11, 2023 |
| Bank of America | Buy | Buy | Maintain | Sep 26, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 12, 2018 |
| Stifel | Hold | Hold | Maintain | Sep 12, 2018 |
| Vertical Research | Buy | Hold | Upgrade | Jan 3, 2017 |
| Susquehanna | Neutral | Neutral | Maintain | Oct 7, 2016 |
| Bernstein | Outperform | Market Perform | Upgrade | Jun 10, 2016 |
| Nomura | Buy | Buy | Maintain | Mar 7, 2016 |
| William Blair | Market Perform | Outperform | Downgrade | Dec 16, 2015 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Nov 3, 2015 |
| Global Hunter Securities | Buy | Buy | Maintain | Oct 18, 2013 |
| Ascendiant Capital | Neutral | Buy | Downgrade | Oct 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $188.83. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Wells Fargo | Stephen Tusa | $229 | $187.89 | +21.3% | Sep 24, 2026 |
| RBC Capital | Analyst unavailable | $227 | $203.68 | +20.2% | Jul 24, 2026 |
| Robert W. Baird | Michael Halloran | $270 | $197.8 | +43.0% | Jul 24, 2026 |
| BMO Capital | Daniel DiCicco | $240 | $197.8 | +27.1% | Jul 24, 2026 |
| Wolfe Research | Nigel Coe | $262 | $213.55 | +38.7% | Jul 9, 2026 |
| Morgan Stanley | Christopher Snyder | $230 | $215.74 | +21.8% | Jun 4, 2026 |
| Seaport Global | Analyst unavailable | $265 | $224.49 | +40.3% | Apr 28, 2026 |
| Deutsche Bank | Analyst unavailable | $229 | $227.3 | +21.3% | Apr 24, 2026 |
| RBC Capital | Analyst unavailable | $252 | $227.3 | +33.5% | Apr 24, 2026 |
| BMO Capital | Daniel DiCicco | $250 | $228.47 | +32.4% | Apr 24, 2026 |
| Oppenheimer | Bryan Blair | $250 | $228.15 | +32.4% | Apr 24, 2026 |
| Robert W. Baird | Michael Halloran | $279 | $228.15 | +47.8% | Apr 24, 2026 |
| Barclays | Julian Mitchell | $230 | $228.15 | +21.8% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $237 | $209.21 | +25.5% | Mar 26, 2026 |
| Morgan Stanley | Christopher Snyder | $210 | $216.32 | +11.2% | Feb 4, 2026 |
| Seaport Global | Analyst unavailable | $245 | $210.52 | +29.7% | Feb 3, 2026 |
| Barclays | Analyst unavailable | $206 | $201.49 | +9.1% | Feb 2, 2026 |
| Goldman Sachs | Analyst unavailable | $224 | $201.49 | +18.6% | Jan 31, 2026 |
| RBC Capital | Analyst unavailable | $209 | $202.53 | +10.7% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $255 | $204.72 | +35.0% | Jan 30, 2026 |
| Oppenheimer | Analyst unavailable | $232 | $207.49 | +22.9% | Jan 26, 2026 |
| RBC Capital | Deane Dray | $199 | $207.64 | +5.4% | Jan 15, 2026 |
| Wells Fargo | Joseph O'Dea | $205 | $203.5 | +8.6% | Jan 7, 2026 |
| UBS | Amit Mehrotra | $256 | $195.75 | +35.6% | Jan 4, 2026 |
| BNP Paribas | Analyst unavailable | $195 | $190.27 | +3.3% | Dec 4, 2025 |
| Morgan Stanley | Analyst unavailable | $195 | $178.94 | +3.3% | Oct 28, 2025 |
| RBC Capital | Deane Dray | $198 | $179.82 | +4.9% | Oct 24, 2025 |
| Robert W. Baird | Analyst unavailable | $235 | $179.82 | +24.5% | Oct 24, 2025 |
| UBS | Analyst unavailable | $200 | $179.82 | +5.9% | Oct 24, 2025 |
| RBC Capital | Deane Dray | $206 | $186.5 | +9.1% | Jul 25, 2025 |
| Mizuho Securities | Brett Linzey | $215 | $186.7 | +13.9% | May 16, 2025 |
| RBC Capital | Analyst unavailable | $176 | $169.01 | -6.8% | Apr 25, 2025 |
| Morgan Stanley | Christopher Snyder | $185 | $163.66 | -2.0% | Apr 14, 2025 |
| Barclays | Analyst unavailable | $205 | $184.22 | +8.6% | Mar 26, 2025 |
| Wells Fargo | Joseph O'Dea | $200 | $187.98 | +5.9% | Jan 7, 2025 |
| UBS | Amit Mehrotra | $217 | $176.23 | +14.9% | Nov 13, 2024 |
| Goldman Sachs | Joe Ritchie | $202 | $191.84 | +7.0% | Oct 30, 2024 |
| Wolfe Research | Nigel Coe | $227 | $191.03 | +20.2% | Oct 28, 2024 |
| Bank of America Securities | Andrew Obin | $210 | $192.79 | +11.2% | Oct 17, 2024 |
| Oppenheimer | Bryan Blair | $215 | $191.28 | +13.9% | Oct 16, 2024 |
| Citigroup | Andrew Kaplowitz | $218 | $189.12 | +15.4% | Sep 23, 2024 |
| RBC Capital | Deane Dray | $193 | $187.03 | +2.2% | Jul 26, 2024 |
| Robert W. Baird | Michael Halloran | $219 | $186.32 | +16.0% | Jul 25, 2024 |
| RBC Capital | Deane Dray | $179 | $173.2 | -5.2% | Apr 4, 2024 |
| Seaport Global | Walt Liptak | $190 | $159.99 | +0.6% | Feb 5, 2024 |
| Morgan Stanley | Analyst unavailable | $152 | $152.88 | -19.5% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $157 | $154.66 | -16.9% | Feb 1, 2023 |
| Credit Suisse | Analyst unavailable | $174 | $152.35 | -7.9% | Feb 1, 2023 |
| Morgan Stanley | Joshua Pokrzywinski | $139 | $119.36 | -26.4% | Oct 12, 2022 |
| Deutsche Bank | Nicole DeBlase | $132 | $128.25 | -30.1% | Jul 22, 2022 |
| Morgan Stanley | Joshua Pokrzywinski | $149 | $133.19 | -21.1% | Jun 7, 2022 |
| Morgan Stanley | Analyst unavailable | $161 | $140.87 | -14.7% | Apr 22, 2022 |
| Barclays | Analyst unavailable | $155 | $140.86 | -17.9% | Apr 22, 2022 |
| Wells Fargo | Analyst unavailable | $159 | $141 | -15.8% | Apr 22, 2022 |
| RBC Capital | Analyst unavailable | $162 | $144.16 | -14.2% | Apr 22, 2022 |
| Barclays | Julian Mitchell | $190 | $153.92 | +0.6% | Apr 5, 2022 |
| Deutsche Bank | Nicole Deblase | $176 | $178.77 | -6.8% | Jan 10, 2022 |
| Wells Fargo | Joseph O'Dea | $184 | $168.44 | -2.6% | Dec 20, 2021 |
| Bank of America Securities | Andrew Obin | $205 | $167.82 | +8.6% | Oct 20, 2021 |
Track every rating change on DOV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationDover Corporation operates as a global enterprise, supplying a wide array of industrial equipment, essential components, consumable products, replacement parts, software and digital platforms, and comprehensive support services. Its Engineered Products division delivers diverse machinery, parts, software, and solutions tailored for various industries, including automotive aftermarket service, waste management, industrial automation, aerospace and defense, heavy-duty winching and hoisting, and fluid dispensing. This segment also manufactures specific items such as manual and power clamps, rotary and linear mechanical indexers, conveyors, robotic pick-and-place units, glove ports, manipulators, and end-of-arm tooling like grippers, slides, and end effectors. The Clean Energy & Fueling segment focuses on providing components, equipment, software, and services crucial for the secure transportation of both traditional and sustainable fuels, along with other hazardous materials, throughout the supply chain.…
Historical context
All DOV earningsIndustrials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| DAL Delta Air Lines, Inc. | FY2026 Q3 · Calendar Q4 2026 | -2.8% | +0.0% | Delta reports strong Q3 demand while costs and capacity remain key watchpoints |
| CTAS Cintas Corporation | FY2027 Q1 · Calendar Q3 2026 | +3.0% | -3.4% | Cintas raises FY2027 guidance as Q1 growth broadens |
| PAYX Paychex, Inc. | FY2027 Q1 · Calendar Q3 2026 | +1.5% | -8.8% | Paychex maintains FY27 outlook as PEO and AI momentum strengthen |
| FPS Forgent Power Solutions, Inc. | FY2026 Q4 · Calendar Q3 2026 | +4.3% | +9.5% | Forgent Power Solutions pairs record results with an aggressive FY27 buildout |
| CPRT Copart, Inc. | FY2026 Q4 · Calendar Q3 2026 | -8.7% | -2.6% | Copart pairs international growth with ACV investment amid higher costs |
| SUNB Sunbelt Rentals Holdings Inc | FY2027 Q1 · Calendar Q3 2026 | +19.2% | +5.9% | Sunbelt raises FY27 outlook as specialty rental demand accelerates |
Latest beats and misses
Who reports nextBeat on EPS
Get the DOV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-04-10T00:01:43.729046+00:00
- Polygon adjusted daily market bars · 2026-10-12T02:50:43.960954+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-12T02:50:43.958183+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-12. For educational purposes only; not investment advice.